Amgen Reports Third Quarter 2017 Financial Results

THOUSAND OAKS, Calif., Oct. 25, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2017. Key results include:

Total revenues decreased 1 percent versus the third quarter of 2016 to $5.8 billion.

GAAP earnings per share (EPS) increased 3 percent to $2.76.

GAAP operating income decreased 3 percent to $2.4 billion and GAAP operating margin decreased 1.1 percentage points to 44.7 percent. 

GAAP EPS and operating income were impacted by non-cash charges associated with the Company's decision to discontinue internal development of AMG 899, an oral CETP inhibitor.

Non-GAAP EPS increased 8 percent to $3.27 driven b...

Source: Amgen News Release - October 25, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news